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Is the length of the paper justified? Yes

Should the paper be seen by a specialist statistical reviewer? No
Is it clear how to make all supporting data available? Not Applicable
Is the supplementary material necessary; and if so is it adequate and clear? Not Applicable
Do you have any ethical concerns with this paper? No
Comments to the Author 1) The major emphasis is on the work of the authors and hence on the basal lamina and interactions of the neural stem cells with these. Chondroitin sulfate proteoglycans are mentioned, but solely with reference to chondroitinase ABC treatment. Some information relating to the types of chondroitin sulfate and the families of core proteins that expose them should be provided.
2) The authors also mention heparin sulfate proteoglycans. They might mention that both syndecans and glypicans have been distinguished in neural tissues. Some of these proteoglycans regulate integrin functions, which is one focus of the review.
3) The authors discuss laminins and also their potential roles in FGF-signalling towards neural stem cells. Therefore, they should mention the fractones, laminin-based structures that have been proposed to serve as storage scaffolds for FGF2.
4) The authors devote some attention to reelin; therefore, they should also briefly comment on the classical signalling pathway. figure 3 the authors show the formation of gyri in an explant of human neocortex. They should specify how the matrix components were applied to the tissue -as soluble proteins or as plasmids/viruses? While details are part of the publication cited some information should be summarized here to obtain an understanding of experiment that is documented. 6) Because hyaluronic acid seems important in controlling neural folding the human cortex the authors might comment the expression of lecticans in the model they discuss. 7) In figure 1 E the presentation could be improved. While in the panels A-D it is indicated whether Itgs are blocked or stimulated this information is missing in the graphic scheme. Thereby it lacks clarity, it is not apparent whether stimulation or deletion/inactivation of the ECM components or receptors causes the effects regarding stem cell proliferation.
5) In
Decision letter (RSOB-18-0216.R0) 27-Nov-2018 Dear Dr Long, We are pleased to inform you that your manuscript RSOB-18-0216 entitled "How the extracellular matrix shapes neural development" has been accepted by the Editor for publication in Open Biology. The reviewer has recommended publication, but also suggest some minor revisions to your manuscript. Therefore, we invite you to respond to the reviewer's comments and revise your manuscript.
Please submit the revised version of your manuscript within 14 days. If you do not think you will be able to meet this date please let us know immediately and we can extend this deadline for you.
To revise your manuscript, log into https://mc.manuscriptcentral.com/rsob and enter your Author Centre, where you will find your manuscript title listed under "Manuscripts with Decisions." Under "Actions," click on "Create a Revision." Your manuscript number has been appended to denote a revision.
You will be unable to make your revisions on the originally submitted version of the manuscript. Instead, please revise your manuscript and upload a new version through your Author Centre.
When submitting your revised manuscript, you will be able to respond to the comments made by the referee(s) and upload a file "Response to Referees" in "Section 6 -File Upload". You can use this to document any changes you make to the original manuscript. In order to expedite the processing of the revised manuscript, please be as specific as possible in your response to the referee(s). Please see our detailed instructions for revision requirements https://royalsociety.org/journals/authors/author-guidelines/.
Before uploading your revised files please make sure that you have: 1) A text file of the manuscript (doc, txt, rtf or tex), including the references, tables (including captions) and figure captions. Please remove any tracked changes from the text before submission. PDF files are not an accepted format for the "Main Document".
2) A separate electronic file of each figure (tiff, EPS or print-quality PDF preferred). The format should be produced directly from original creation package, or original software format. Please note that PowerPoint files are not accepted.
3) Electronic supplementary material: this should be contained in a separate file from the main text and meet our ESM criteria (see http://royalsocietypublishing.org/instructionsauthors#question5). All supplementary materials accompanying an accepted article will be treated as in their final form. They will be published alongside the paper on the journal website and posted on the online figshare repository. Files on figshare will be made available approximately one week before the accompanying article so that the supplementary material can be attributed a unique DOI.
Online supplementary material will also carry the title and description provided during submission, so please ensure these are accurate and informative. Note that the Royal Society will not edit or typeset supplementary material and it will be hosted as provided. Please ensure that the supplementary material includes the paper details (authors, title, journal name, article DOI). Your article DOI will be 10.1098/rsob.2016[last 4 digits of e.g. 10.1098/rsob.20160049]. 4) A media summary: a short non-technical summary (up to 100 words) of the key findings/importance of your manuscript. Please try to write in simple English, avoid jargon, explain the importance of the topic, outline the main implications and describe why this topic is newsworthy.
Images
We require suitable relevant images to appear alongside published articles. Do you have an image we could use? Images should have a resolution of at least 300 dpi, if possible.
Data-Sharing
It is a condition of publication that data supporting your paper are made available. Data should be made available either in the electronic supplementary material or through an appropriate repository. Details of how to access data should be included in your paper. Please see http://royalsocietypublishing.org/site/authors/policy.xhtml#question6 for more details.
Data accessibility section
To ensure archived data are available to readers, authors should include a 'data accessibility' section immediately after the acknowledgements section. This should list the database and accession number for all data from the article that has been made publicly available, for instance: 1) The major emphasis is on the work of the authors and hence on the basal lamina and interactions of the neural stem cells with these. Chondroitin sulfate proteoglycans are mentioned, but solely with reference to chondroitinase ABC treatment. Some information relating to the types of chondroitin sulfate and the families of core proteins that expose them should be provided.
5) In
Author's Response to Decision Letter for (RSOB-18-0216.R0)
See Appendix A.
Decision letter (RSOB-18-0216.R1) 11-Dec-2018 Dear Dr Long
We are pleased to inform you that your manuscript entitled "How the extracellular matrix shapes neural development" has been accepted by the Editor for publication in Open Biology.
You can expect to receive a proof of your article from our Production office in due course, please check your spam filter if you do not receive it within the next 10 working days. Please let us know if you are likely to be away from e-mail contact during this time.
Thank you for your fine contribution. On behalf of the Editors of Open Biology, we look forward to your continued contributions to the journal.
Sincerely,
The Open Biology Team mailto: openbiology@royalsociety.org
